What Clinicians Should Expect Next May 11, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,425 views The rapid rise of GLP-1 receptor agonists has transformed diabetes treatment and obesity management over the past decade
When GLP-1 is Appropriate Your thyroid levels are stable You are on a consistent levothyroxine routine You struggle with weight loss despite diet and exercise You have Hashimotos or primary hypothyroidism and want better metabolic control When GLP-1 is Not Recommended You have MTC You have MEN2 You have uncontrolled hypothyroidism (TSH extremely high) Key Monitoring Guidelines When I start a hypothyroid patient on GLP-1, I monitor: TSH every 68 weeks T3 and T4, depending on symptoms Heart rate Energy levels GI symptoms Appetite changes How GLP-1 Medications Work I always describe GLP-1 medications in a way patients can visualize: 1
10.3389/fimmu.2021.708101 Front Immunol
Once-weekly semaglutide for weight management: a clinical review
Physical activity levels can also influence plateaus
Cancer risk associated with lorcaserinthe FDAs review of the CAMELLIA-TIMI 61 trial